Grant Pickering - May 27, 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
/s/ Winston Macaraeg, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
May 27, 2021
Transactions value $
-$302,819
Form type
4
Date filed
5/28/2021, 08:18 PM
Previous filing
Feb 5, 2024
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $21.9K +12.2K +2.11% $1.79 593K May 27, 2021 Direct F1
transaction PCVX Common Stock Sale -$271K -12.2K -2.07% $22.10 580K May 27, 2021 Direct F2, F3
transaction PCVX Common Stock Options Exercise $4.75K +2.66K +0.46% $1.79 583K May 28, 2021 Direct
transaction PCVX Common Stock Sale -$58.9K -2.66K -0.46% $22.16 580K May 28, 2021 Direct F2, F4
holding PCVX Common Stock 356K May 27, 2021 By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -12.2K -2.73% $0.00 437K May 27, 2021 Common Stock 12.2K $1.79 Direct F5
transaction PCVX Stock Option (right to buy) Options Exercise $0 -2.66K -0.61% $0.00 434K May 28, 2021 Common Stock 2.66K $1.79 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,563 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported is a weighted-average price. The shares were sold at prices ranging from $22.00 to $22.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The price reported is a weighted-average price. The shares were sold at prices ranging from $22.00 to $22.405. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The shares subject to the option are fully vested and exercisable.